Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: J Pediatr Urol. 2020 Jun 11;16(4):466.e1–466.e9. doi: 10.1016/j.jpurol.2020.05.163

Table 1.

Control and UPJO patient characteristics

Control UPJO
Number of samples 22 22
Sex M M
Age - Average (SD) 8.3 (3.0) months 6.0 (3.8) months
Weight - Average (SD) 8.5 (1.3) kg 7.3 (1.7) kg
Patients Hypospadias repair Confirmed obstruction - Mag-3 t1/2 >20min with differential function <40% in the affected side
Notes Control-12 was used for mass spectrometric analysis only. Remaining samples were used for both mass spectrometric analysis and ELISA. UPJO-6, 7, 8 and 21 were used for mass spectrometric analysis only, while UPJO-1 was used for ELISA only. Remaining samples were used for both the analyses.

Due to the limited availability, some of the samples were used for either mass spectrometric analysis or ELISA and have been identified in the notes.